Officer sold ~$230K of Gilead Sciences
Scheduled in advanceLoading…
Chief Commercial Officer
Disclosures on record
50
Companies involved
1
Officer sold ~$230K of Gilead Sciences
Scheduled in advanceOfficer sold ~$116K of Gilead Sciences
Scheduled in advanceOfficer sold ~$87K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Officer sold ~$2.27M of Gilead Sciences
Scheduled in advanceOfficer sold ~$1.58M of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$390K of Gilead Sciences
Scheduled in advanceOfficer sold ~$183K of Gilead Sciences
Scheduled in advanceOfficer sold ~$133K of Gilead Sciences
Scheduled in advanceOfficer sold ~$56K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Officer sold ~$1.47M of Gilead Sciences
Scheduled in advanceOfficer sold ~$1.11M of Gilead Sciences
Scheduled in advanceOfficer sold ~$1.01M of Gilead Sciences
Scheduled in advanceOfficer sold ~$93K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$423K of Gilead Sciences
Scheduled in advanceOfficer sold ~$433K of Gilead Sciences
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Officer sold ~$2.84M of Gilead Sciences
Scheduled in advanceOfficer sold ~$1.46M of Gilead Sciences
Scheduled in advanceOfficer sold ~$31K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Officer sold ~$373K of Gilead Sciences
Scheduled in advanceOfficer sold ~$366K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Officer sold ~$3.21M of Gilead Sciences
Scheduled in advanceOfficer sold ~$313K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$354K of Gilead Sciences
Scheduled in advance